Rational design and research progress of novel mitochondrial uncouplers.
文献摘要
Mitochondrial uncouplers have been validated as effective therapeutic agents in preclinical models of metabolic dysfunction-associated diseases, including obesity, type 2 diabetes mellitus (T2DM), metabolic dysfunction-associated steatotic liver disease (MASLD), cardiovascular diseases and tumors. In this review, we briefly summarize the biological functions and therapeutic potential of uncouplers, with a primary focus on advances in their chemical-structural optimization. We mainly recapitulate the design optimization strategies and developmental routes of representative scaffolds among protonophore‑type uncouplers, and analyze the design approaches for cutting‑edge protein‑dependent uncouplers. Finally, we provide a critical evaluation of the current dilemmas, research trends and future research directions in the field of uncouplers to provide meaningful references for future investigations.